



(tirzepatide) injection
Zepbound contains tirzepatide, a dual-action GLP-1/GIP receptor agonist. It’s FDA-approved for adults with obesity, or overweight plus a weight-related condition, to be used alongside diet and exercise.
Zepbound and Wegovy are FDA-approved for weight loss, while Ozempic is FDA-approved for type 2 diabetes but can be prescribed off-label for weight management. Unlike semaglutide in Ozempic or Wegovy, tirzepatide works on two receptors to reduce hunger and regulate metabolism, helping you feel full faster and longer.
Safety Information: GLP-1 medications like Zepbound are for adults with obesity or overweight plus weight-related conditions, along with diet and exercise. Serious side effects are possible, including thyroid tumors. Do not use if you or your family have a history of MTC or MEN 2. Always review full safety information.
Zepbound works by targeting two hormone receptors, GLP-1 and GIP, to help curb hunger and regulate metabolism.